Why the study?
Does antiplatelet therapy prevent stroke in patients with nonvalvular atrial fibrillation and no previous history of stroke or transient ischemic attacks?
Does antiplatelet therapy prevent stroke in patients with nonvalvular atrial fibrillation and no previous history of stroke or transient ischemic attacks?
Antiplatelet agents offer modest efficacy for stroke prevention in nonvalvular atrial fibrillation patients who do not receive oral anticoagulants.
May support antiplatelet use in anticoagulation-ineligible AF; leaves open need for updated comparative trials.
A ntiplatelet agents such as aspirin are modestly effica- cious for preventing serious vascular events in patients with atrial fibrillation (AF) who are not treated with more efficacious oral anticoagulants.
No takes yet. Share an insight, caveat, or question.
Aguilar et al. (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: